转自：北京日报客户端 随着冬季气温日渐走低，一款名为"光腿神器"的肤色紧身打底裤因兼具时尚感与保暖性，一跃成为寒冬 街头常见的穿搭单品。而社交媒体上频频曝出的健康风险案例却也敲响警钟："保暖神器"可能成为损害 健康的"美丽负担"。 图源：央 近日，"女孩穿光腿神器进了急诊"的话题更是在网络上掀起热议。如何在追求"风度"的同时，兼顾身体 的温度与健康？国家应急广播特别专访首都医科大学附属北京世纪坛医院血管外科主任罗小云与整形外 科副主任高磊。 女孩长时间穿"光腿神器" 身体不适进急诊 "我从下午穿到晚上，刚开始只是觉得有点勒，后来就感觉胸闷、呼吸困难，腿也开始发麻。"近日，用 户小张在社交平台发帖称，自己因长时间穿着紧身"光腿神器"而感到身体不适，最终不得不前往医院急 诊。 小张称，她当天为参加一场重要活动，特意选择了加厚款"光腿神器"，希望能在保暖的同时保持优雅形 象。然而连续穿着数小时后，她逐渐感到身体不适，最终在家人陪同下前往医院。 视新闻 小张的分享迅速引发共鸣，许多网友纷纷留言表示有过类似经历： "光腿神器"="美丽负担"？ "光腿神器"引发的健康隐患，绝非危言耸听。罗小云与高磊表示，主要需考量四方面 ...

（来源：科普中国） 转自：科普中国 裸色打底裤，因其隐形又保暖、拍照显得像真的光腿一般的效果，一直有着"光腿神器"的美誉，在冬天销量十分可观。 但最近，"女孩穿光腿神器进了急诊"相关话题引发关注↓ 有用户在社交平台发帖称，自己因长时间穿着紧身"光腿神器"而感到身体不适，最终不得不前往医院急诊就诊。 发帖者小张称，自己当天为了参加一场重要活动，特意选择了加厚款的"光腿神器"，希望能在保暖的同时保持优雅形象。然而连续穿数小时后，她逐渐感 到不适，最终在家人陪同下前往医院。 小张的分享迅速引发共鸣，许多网友纷纷留言表示有过类似经历： 最早的初代"光腿神器"还只是追求跟肤色的相近，后来随着人们的需求变化，很多"光腿神器"都增加"压力"，有些女生为了显瘦，一味追求"压力大"的"光 腿神器"，殊不知，这种过度紧致的连裤袜，会带来许多"美丽的代价"。 1 轻则便秘、重则痔疮，还可能引发妇科炎症 "光腿神器"由于裤腰过紧，会对腰腹盆腔造成过大压力，尤其是肛周静脉循环受限，直肠肝门静脉血回流减缓，轻则会引发便秘，严重者甚至会导致痔疮 的发生。对于女性而言，盆底位置如果过紧，阴道分泌物增加，肛周细菌向前转移，而且还不透气，更容易 ...

Core Viewpoint - The company Steady Medical (300888) is actively engaging with investors regarding strategic opportunities and product development aligned with health and sustainability goals [2]. Group 1: Stock Performance - As of November 3, 2025, Steady Medical's stock closed at 40.91 yuan, down 0.94%, with a turnover rate of 1.08%, a trading volume of 62,900 shares, and a transaction value of 258 million yuan [1]. Group 2: Investor Relations - The company is open to introducing strategic investors and will disclose any significant plans in accordance with legal requirements [2]. - The chairman has emphasized the goal of creating sustainable products that promote longevity, safety, and health, aligning with the company's vision of "caring for health, loving life, and protecting the environment" [2]. Group 3: Product Offerings - Steady Medical offers a range of products under its main brands "winner Steady Medical" and "Purcotton," covering various segments such as wound care, infection protection, surgical supplies, personal care, family care, maternal and infant care, and home textiles [2]. - The company has multiple models of varicose vein socks available for purchase through its official online platforms [2]. Group 4: Market Activity - On November 3, the net outflow of funds from major investors was 9.61 million yuan, while retail investors saw a net inflow of 17.91 million yuan [2].

Meeting Agenda - The 2024 Annual General Meeting of Shareholders will cover various reports including the independent director's report, financial settlement report, profit distribution proposal, and proposals for foreign exchange trading and credit limits for subsidiaries [1][2][3] Company Performance - In 2023, the company achieved a revenue of 4.264 billion yuan, a 3.32% increase year-on-year, with a net profit attributable to shareholders of 385 million yuan, a 94.14% increase [4][5] - The revenue from isolation protective products was 160 million yuan, a decrease of 4.23 billion yuan year-on-year, while excluding these products, the revenue grew by 15.80% [4][5] Market Strategy - The company focuses on core areas such as surgical infection control and rehabilitation, enhancing market competitiveness through strategic planning and operational efficiency [6][7] - The company has expanded its coverage to nearly 9,000 hospitals across China, with over 1,200 being top-tier hospitals [6] Retail Market Development - The company has achieved a retail revenue of 594 million yuan, with a 9.77% increase year-on-year when excluding isolation protective products [8] - The company has established a strong presence in both online and offline retail channels, covering 99% of the top 100 pharmacy chains in China [7][8] International Expansion - The company is actively developing production bases in Africa and Mexico to enhance its international market competitiveness and meet diverse supply chain needs [9][10] - The overseas revenue reached 2.475 billion yuan, a 14.64% increase year-on-year, driven by strong performance in Southeast Asia and the Middle East [10] Research and Development - The company has focused on innovative product development in areas such as wound care and infection control, with significant investments in R&D [11][12] - The company has obtained 9 new medical device registrations and 28 patents, totaling 105 patents and 136 medical device registrations [12] Governance and Compliance - The board of directors has adhered to legal regulations and company bylaws, ensuring compliance and effective decision-making [19][20] - The company has implemented a profit distribution plan, distributing a total of 133.16 million yuan in cash dividends [21] Future Plans - The company aims to enhance its governance structure, expand market penetration, and strengthen R&D investments in 2025 [22][23] - The company will focus on product strategy, brand building, and digital transformation to improve operational efficiency and market presence [24][25]